Piccinini J, Sanz Perl Y, Pallavicini C, Deco G, Kringelbach M, Nutt D
Commun Biol. 2025; 8(1):409.
PMID: 40069397
PMC: 11897362.
DOI: 10.1038/s42003-025-07576-0.
Haggarty C, Molla H, Glazer J, Tare I, Rains A, de Wit H
Psychedelic Med (New Rochelle). 2025; 2(4):210-220.
PMID: 40051483
PMC: 11658383.
DOI: 10.1089/psymed.2024.0005.
Torrado Pacheco A, Moghaddam B
J Clin Invest. 2025; 134(12).
PMID: 40047885
PMC: 11178541.
DOI: 10.1172/JCI180217.
Lepow L, Kronman H, Yehuda R
Psychedelic Med (New Rochelle). 2025; 1(4):190-194.
PMID: 40046859
PMC: 11658663.
DOI: 10.1089/psymed.2023.0031.
W Gongwer M, Qi A, Enos A, Rueda S, Rueda Mora S, Klune C
bioRxiv. 2025; .
PMID: 39975365
PMC: 11838264.
DOI: 10.1101/2025.01.29.635537.
Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use.
Glynos N, Baker A, Aday J, Kruger D, Boehnke K, Lake S
Br J Pain. 2025; :20494637251319497.
PMID: 39944237
PMC: 11811946.
DOI: 10.1177/20494637251319497.
Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression.
Aboharb F, Davoudian P, Shao L, Liao C, Rzepka G, Wojtasiewicz C
Nat Commun. 2025; 16(1):1590.
PMID: 39939591
PMC: 11822132.
DOI: 10.1038/s41467-025-56850-6.
Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis.
van der Heijden K, Otto M, Schoones J, van Esdonk M, Borghans L, van Hasselt J
Clin Pharmacokinet. 2025; 64(2):215-227.
PMID: 39838235
PMC: 11782443.
DOI: 10.1007/s40262-024-01450-8.
Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.
Henderson I, Elsaadany R, Chan G, Bajaj V, Duarte D, Goodman S
Curr Pain Headache Rep. 2025; 29(1):28.
PMID: 39820774
DOI: 10.1007/s11916-024-01321-8.
Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.
Otto M, van der Heijden K, Schoones J, van Esdonk M, Borghans L, Jacobs G
Clin Pharmacokinet. 2025; 64(1):53-66.
PMID: 39812743
PMC: 11762572.
DOI: 10.1007/s40262-024-01454-4.
What should constitute a control condition in psychedelic drug trials?.
Colloca L, Fava M
Nat Ment Health. 2025; 2(10):1152-1160.
PMID: 39781538
PMC: 11709123.
DOI: 10.1038/s44220-024-00321-2.
Structural neural plasticity evoked by rapid-acting antidepressant interventions.
Liao C, Dua A, Wojtasiewicz C, Liston C, Kwan A
Nat Rev Neurosci. 2024; 26(2):101-114.
PMID: 39558048
PMC: 11892022.
DOI: 10.1038/s41583-024-00876-0.
Pyramidal cell types and 5-HT receptors are essential for psilocybin's lasting drug action.
Shao L, Liao C, Davoudian P, Savalia N, Jiang Q, Wojtasiewicz C
bioRxiv. 2024; .
PMID: 39554087
PMC: 11566025.
DOI: 10.1101/2024.11.02.621692.
Increased functional connectivity between brain regions involved in social cognition, emotion and affective-value in psychedelic states induced by N,N-Dimethyltryptamine (DMT).
Soares C, Lima G, Pais M, Teixeira M, Cabral C, Castelo-Branco M
Front Pharmacol. 2024; 15:1454628.
PMID: 39539622
PMC: 11558042.
DOI: 10.3389/fphar.2024.1454628.
Ventral hippocampal parvalbumin interneurons gate the acute anxiolytic action of the serotonergic psychedelic DOI.
Tiwari P, Davoudian P, Kapri D, Vuruputuri R, Karaba L, Sharma M
Neuron. 2024; 112(22):3697-3714.e6.
PMID: 39321791
PMC: 11581910.
DOI: 10.1016/j.neuron.2024.08.016.
The serotonergic psychedelic DOI impairs deviance detection in the auditory cortex.
Horrocks M, Mohn J, Jaramillo S
bioRxiv. 2024; .
PMID: 39314372
PMC: 11418932.
DOI: 10.1101/2024.09.06.611733.
CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.
Gobbi G
J Psychiatry Neurosci. 2024; 49(5):E301-E318.
PMID: 39299781
PMC: 11426389.
DOI: 10.1503/jpn.240037.
Single-dose 1cp-LSD administration for canine anxiety: a pilot study.
Henriquez-Hernandez L, Garcia-Serrano I, Quintana-Hernandez D, Rojas-Hernandez J, Hernandez-Alvarez E, Zumbado M
Vet Res Commun. 2024; 48(6):4007-4014.
PMID: 39287896
PMC: 11538183.
DOI: 10.1007/s11259-024-10542-6.
A Computational Account of the Development and Evolution of Psychotic Symptoms.
Powers A, Angelos P, Bond A, Farina E, Fredericks C, Gandhi J
Biol Psychiatry. 2024; 97(2):117-127.
PMID: 39260466
PMC: 11634669.
DOI: 10.1016/j.biopsych.2024.08.026.
Disrupted Human-Dog Interbrain Neural Coupling in Autism-Associated Shank3 Mutant Dogs.
Ren W, Yu S, Guo K, Lu C, Zhang Y
Adv Sci (Weinh). 2024; 11(41):e2402493.
PMID: 39257367
PMC: 11538694.
DOI: 10.1002/advs.202402493.